[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353501-105":59,"doc-detail-353501-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","unraveling-risk-factors-and-transcriptomic-signatures-in-liver-cancer-progression-and-mortality-through-machine-learning-and-bioinformatics","Unraveling risk factors and transcriptomic signatures in liver cancer progression and mortality through machine learning and bioinformatics","","Liver cancer ranks among the leading causes of cancer mortality worldwide, while the molecular mechanisms connecting its progression to associated risk factors remain insufficiently characterized. An integrative multi-stage framework was built using bioinformatics, machine learning feature selection, survival modeling, and network analysis to nominate robust biomarkers and pathways. Differentially expressed genes were derived from three GEO datasets, followed by a diseasome network, Cox models with TCGA RNA-seq and clinical data, enrichment and protein–protein interaction analyses, and independent validation using the full TCGA transcriptome.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/unraveling-risk-factors-and-transcriptomic-signatures-in-liver-cancer-progression-and-mortality-through-machine-learning-and-bioinformatics/353501/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/unraveling-risk-factors-and-transcriptomic-signatures-in-liver-cancer-progression-and-mortality-through-machine-learning-and-bioinformatics/353501.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-17","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the main goal of the study on liver cancer progression and mortality?","Question",{"text":113,"@type":114},"To uncover molecular mechanisms that link liver cancer progression with associated risk factors by identifying robust biomarkers and pathways using integrative computational analyses.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were risk-associated genes and biomarkers identified?",{"text":118,"@type":114},"Differentially expressed genes were obtained from three GEO datasets, shared biomarkers were used to build a gene-disease association network, and TCGA-based RNA-seq with clinical data was analyzed with combined and multivariate Cox survival models.",{"name":120,"@type":111,"acceptedAnswer":121},"Which modeling and validation steps were used to assess prognostic value?",{"text":122,"@type":114},"Enrichment and protein–protein interaction network analyses were performed for the prognostic gene set, and an independent survival analysis using the full TCGA transcriptomic dataset confirmed significant genes and overlaps with the risk-associated set.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},353501,1790197667,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","Briefings in Functional Genomics, 2026, 25, elaf019  \n[https://doi.org/10.1093/bfgp/elaf019](https://doi.org/10.1093/bfgp/elaf019)  \nProtocol and Method Article  \nUnraveling risk factors and transcriptomic signatures in liver cancer progression and mortality through machine learning and bioinformatics  \nTania Akter Asa1 , 2 ,†, Md. Ali Hossain1 , 3 ,†, Md Shahjahan Ali4 , Md. Zulfiker Mahmud2 , *, AKM Azad 5 , Mohammad Zahidur Rahman3 , Mohammad Ali Moni 6 , 7 , *  \n1NanoBio Technology Center, Daffodil International University, Birulia, Savar, Dhaka-1216, Bangladesh  \n2 Dept of Computer Science and Engineering, Jagannath University, 9-10 Chittaranjan Avenue, Sadarghat, Dhaka-1100, Bangladesh  \n3 Dept of Computer Science and Engineering, Jahangirnagar University, Savar, Dhaka-1342, Bangladesh  \n4 Dept of Electrical and Electronic Engineering, Islamic University, Kushita-7003, Bangladesh  \n5 Department of Mathematics and Statistics, Faculty of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 13318, Kingdom of Saudi Arabia  \n6AI and Digital Health Technology, Artificial Intelligence & Cyber Futures Centre, Charles Sturt University, Bathurst, NSW 2795, Australia  \n7AI and Digital Health Technology, Rural Health Research Institute, Charles Sturt University, Orange, NSW 2800, Australia  \n*Corresponding authors. Md. Zulfiker Mahmud, Dept of Computer Science and Engineering, Jagannath University, Dhaka, Bangladesh.  \nE-mail: [zulfiker@cse.jnu.ac.bd](zulfiker@cse.jnu.ac.bd); Mohammad Ali Moni, AI and Digital Health Technology, Rural Health Research Institute, Charles Sturt University, Orange,  \nNSW 2800, [Australia. E-mail:](Australia. E-mail: mmoni@csu.edu.au)[ mmoni@csu.edu.au](Australia. E-mail: mmoni@csu.edu.au) , [m.moni@uq.edu.au](m.moni@uq.edu.au)[ ](m.moni@uq.edu.au)†Tania Akter Asa and Md. Ali Hossain share first authorship.  \nAbstract  \nLiver cancer (LC) is the second leading cause of cancer-related deaths globally, yet the molecular mechanisms linking its progression with associated risk factors (RFs) remain poorly understood. To address this, we developed an integrative multi-stage framework combining bioinformatics, machine learning-based feature selection, survival modeling, and network analysis to identify robust biomarkers and pathways involved in LC progression. Unlike conventional biomarker discovery approaches, our strategy integrates multi-cohort transcriptomic and clinical datasets, enhancing robustness and reliability of findings. Initially, differentially expressed genes were identified from three Gene Expression Omnibus datasets for LC and its RFs. Next, using shared biomarkers, we constructed a gene-disease association (diseasome) network, revealing 230 unique genes, including 126 shared between LC and liver cirrhosis. Subsequently, RNA-seq and clinical data from The Cancer Genome Atlas (TCGA) were analyzed through combined and multivariate Cox survival models, identifying 70 prognostic genes. Among these, we identified RGS5, SULT1C2, CSM3, and CXCL14 as consistent survival-associated markers. Functional investigation of the 70 genes using enrichment and protein–protein interaction networks uncovered ten hub genes involved in key oncogenic pathways, including Oocyte meiosis, Lysine degradation and cell cycle regulation. These findings were further validated through literature and expression-level analysis. Additionally, an independent survival analysis using the full TCGA transcriptomic dataset identified 76 significant genes, with 18 overlapping the risk-associated gene set, reinforcing their prognostic value. Overall, this study demonstrates the potential of an integrative computational approach to uncover meaningful biomarkers and pathways in LC, offering valuable insights for future clinical and therapeutic strategies.  \nKeywords: liver cancer; risk factors; clinical factors; gene expression; COX PH model; survival analysis; RNA-seq; molecular pathways  \nIntroduction  \nLiver cancer (LC) is","cbCaimgbZ7aef0Sy","https://ap.wps.com/l/cbCaimgbZ7aef0Sy","pdf",3004647,17,"English","# Abstract\n# Keywords\n# Introduction","[{\"question\":\"What was the main goal of the study on liver cancer progression and mortality?\",\"answer\":\"To uncover molecular mechanisms that link liver cancer progression with associated risk factors by identifying robust biomarkers and pathways using integrative computational analyses.\"},{\"question\":\"How were risk-associated genes and biomarkers identified?\",\"answer\":\"Differentially expressed genes were obtained from three GEO datasets, shared biomarkers were used to build a gene-disease association network, and TCGA-based RNA-seq with clinical data was analyzed with combined and multivariate Cox survival models.\"},{\"question\":\"Which modeling and validation steps were used to assess prognostic value?\",\"answer\":\"Enrichment and protein–protein interaction network analyses were performed for the prognostic gene set, and an independent survival analysis using the full TCGA transcriptomic dataset confirmed significant genes and overlaps with the risk-associated set.\"}]","Unraveling risk factors and transcriptomic signatures in liver cancer progression and mortality through machine learning and bioinformatics | PDF",1790105826,43,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6bb9e81a6da86da245d88b9af9053b4c.webp",983,1291,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1a32aa53f04e9c9dcfa0193ca75d05dc.webp",982,1290,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7b2e52d53f5fa7684987bd45a79b1ed2.webp",981,1289,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/42afcf4baf339c7e9876f10d8c727221.webp",980,1287]